Senate Hearing On Ozempic, Wegovy Again Highlights Concerns About PBMs

 
• By Cathy Kelly
  
Senate HELP Committee screenshot
Novo Nordisk CEO Jorgenson Would Not Commit To Lowering Lists Prices For Ozempic, Wegovy. • Source: Screenshot of Senate HELP Committee broadcast

More from Pricing Debate

More from Market Access